Human adenovirus type 8: The major agent of epidemic keratoconjunctivitis (EKC)

Journal of Clinical Virology

Volumn 61, Issue 4, 2014, Pages 477-486

  Adhikary, Arun Kumar ^a   Banik, Urmila ^a  

^a AIMST UNIVERSITY   (Malaysia)

Author keywords

Adenovirus type 8; EKC; Genome type; Molecular analysis

Indexed keywords

CAPSID PROTEIN; EPITOPE; NEUTRALIZING ANTIBODY; RESTRICTION ENDONUCLEASE; HEXON CAPSID PROTEIN, ADENOVIRUS; VIRUS ANTIBODY;

AMINO ACID SEQUENCE; ANTIBODY TITER; ANTIGENICITY; CORNEA CELL; EPIDEMIC; EPIDEMIC KERATOCONJUNCTIVITIS; GENETIC VARIABILITY; HUMAN; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS 53; HUMAN ADENOVIRUS 54; HUMAN ADENOVIRUS 8; KERATOCONJUNCTIVITIS; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; RESTRICTION FRAGMENT; RESTRICTION MAPPING; RESTRICTION SITE; REVIEW; SEROPREVALENCE; VIRAL TROPISM; VIRUS GENOME; ADENOVIRIDAE INFECTIONS; ANIMAL; CLASSIFICATION; GENETICS; GENOTYPE; HUMAN ADENOVIRUS C; IMMUNOLOGY; ISOLATION AND PURIFICATION; KERATOCONJUNCTIVITIS, INFECTIOUS; PHYLOGEOGRAPHY; VIROLOGY;

ADENOVIRIDAE INFECTIONS; ADENOVIRUSES, HUMAN; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CAPSID PROTEINS; GENOTYPE; HUMANS; KERATOCONJUNCTIVITIS, INFECTIOUS; PHYLOGEOGRAPHY;

EID: 84922679370     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2014.10.015     Document Type: Review

References (109)

1. Jones M.S., Harrach B., Ganac R.D., Gozum M.M., Dela Cruz W.P. New adenovirus species found in a patient presenting with gastroenteritis. J Virol 2007, 81:5978-5984.
2. Berk A.J. Adenoviridae. Fields virology 2013, 1704-1731. Lippincott Williams &Wilkins, Philadelphia. 6th ed. D.M. Knipe, P.M. Howley, J.I.J. Cohen, G.E. Griffin, R.A. Lamb, M.A. Martin (Eds.).
3. Wold W.S.M., Ison M.G. Adenoviruses. Fields virology 2013, 1732-1767. Lippincott Williams &Wilkins, Philadelphia. 6th ed. D.M. Knipe, P.M. Howley, J.I. Cohen, G.E. Griffin, R.A. Lamb, M.A. Martin (Eds.).
4. Seto J., Walsh M.P., Mahadevan P., Zhang Q., Seto D. Applying genomic and bioinformatic resources to human adenovirus genomes for use in vaccine development and for applications in vector development for gene delivery. Viruses 2010, 2:1-26.
5. Echavarría M. Adenoviruses in immunocompromised hosts. Clin Microbiol Rev 2008, 21:704-715.
6. Robinson C.M., Singh G., Henquell C., Walsh M.P., Peigue-Lafeuille H., Seto D., et al. Computational analysis and identification of an emergent human adenovirus pathogen implicated in a respiratory fatality. Virology 2011, 409:141-147.
7. Nakamura M., Hirano E., Kowada K., Ishiguro F., Yamagishi Z., Adhikary A.K., et al. Surveillance of adenovirus D in patients with epidemic keratoconjunctivitis from Fukui Prefecture, Japan, 1995-2010. J Med Virol 2012, 84:81-86.
8. Darougor S., Walpita P., Thaker U., Viswalingam N., Gardner L., McSwiggan D.A. Adenovirus serotypes isolated from ocular infections in London. Br J Ophthalmol 1983, 67:111-114.
9. González-López J.J., Morcillo-Laiz R., Muñoz-Negrete F.J. Adenoviral keratoconjunctivitis: an update. Arch Soc Esp Oftalmol 2013, 88:108-115.
10. Adhikary A.K., Banik U., Okabe N., Fujimoto T. Molecular characterization of human adenovirus 8 (HAdV-8) including a novel genome type in Japan. Jpn J Infect Dis 2011, 64:493-498.
11. Zhang Y., Bergelson J.M. Adenovirus receptors. J Virol 2005, 79:12125-12131.
12. Cupelli K., Stehle T. Viral attachment strategies: the many faces of adenoviruses. Curr Opin Virol 2011, 1:84-91.
13. Rosen I. A hemagglutination-inhibition technique for typing of adenoviruses. Am J Hyg 1960, 71:120-128.
14. Hierholzer J.C. Further subgrouping of the human adenoviruses by differential hemagglutination. J Infect Dis 1973, 128:541-550.
15. Kaneko H., Iida T., Ishiko H., Ohguchi T., Ariga T., Tagawa Y., et al. Analysis of the complete genome sequence of epidemic keratoconjunctivitis-related human adenovirus type 8, 19, 37 and a novel serotype. J Gen Virol 2009, 90:1471-1476.
16. Hierholzer J.C. Adenoviruses in the immunocompromised host. Clin Microbiol Rev 1992, 5:262-274.
17. Golden B., McKee A.P. Enhancement of the infectivity titer of adenovirus type 8. Arch Ophthalmol 1970, 83:455-457.
18. Wigand R., Gelderblom H., Ozel M., Distler H., Adrian T. Characteristics of mastadenovirus h8, the causative agent of epidemic keratoconjunctivitis. Arch Virol 1983, 76:307-319.
19. Jawetz E., Thygeson P., Hanna L., Nicholas A., Kimura S. Antibodies to APC virus type 8 in epidemic keratoconjunctivitis. Proc Soc Exp Biol Med 1956, 92:91.
20. Jawetz E. The story of shipward eye. Br Med J 1959, 1:873-878.
21. Guyer B., O'Day D.M., Hierholzer J.C., Schaffner W. Epidemic keratoconjunctivitis: a community outbreak of mixed adenovirus type 8 and type 19 infection. J Infect Dis 1975, 132:142-150.
22. Laibson P.R., Ortolan G., Dupre-Strachan S. Community and hospital outbreak of epidemic keratoconjunctivitis. Arch Ophthalmol 1968, 80:467-473.
23. Sprague J.B., Hierholzer J.C., Currier R.W., Hattwick M.A., Smith M.D. Epidemic keratoconjunctivitis: a severe industrial outbreak due to adenovirus type 8. N Engl J Med 1973, 289:1341-1346.
24. Patrick S., Matthews S. Adenovirus 8 outbreak in ophthalmology department 1981, PHLS Communicable Disease Surveillance Centre, London, [Circular CDR 81/06].
25. Buehler J.W., Finton R.J., Goodman R.A., Choi K., Hierholzer J.C., Sikes R.K., et al. Epidemic keratoconjunctivitis: report of an outbreak in an ophthalmology practice and recommendations for prevention. Infect Control 1984, 5:390-394.
26. D'Angelo L.J., Hierholzer J.C., Holman R.C. Epidemic keratoconjunctivitis caused by adenovirus type 8: epidemiologic and laboratory aspects of a large outbreak. Am J Epidemiol 1981, 113:44-49.
27. Fujii S., Nakazono N., Sawada H., Ishii K., Kato M., Aoki K., et al. Restriction endonuclease cleavage analysis of adenovirus type 8: two new subtype form patients with epidemic keratoconjunctivitis in Sapporo. Jpn J Med Sci Biol 1983, 36:307-313.
28. Fujii S., Nakazono N., Ishii K., Lin C.C., Sheu M.M., Chen C.W., et al. Molecular epidemiology of adenovirus type 8 (Ad 8) in Taiwan: four genotypes recovered during the period of 1908-1981 from patients with epidemic keratoconjunctivitis. Jpn J Med Sci Biol 1984, 37:161-169.
29. Fujii S., Yamashita T. Molecular epidemiology of adenovirus type 8: analysis and identification of viral isolates recovered in Sapporo and Kaohsiung. Sapporo Med J 1984, 53:65-72.
30. Sheu M.M., Huang W.L., Lin K.H., Chen C.W., Lin C.C. A molecular study of adenovirus type 8 isolated from viral conjunctivitis in the Kaohsiung area during 1983-1984: a chronological comparison of genotypes by endonuclease cleavage analysis. Kaohsiung J Med Sci 1987, 3:338-345.
31. Chang C., Sheu M., Chern C., Lin K., Huang W., Chen C. Epidemic keratoconjunctivitis caused by a new genotype of adenovirus type 8 (Ad8) - a chronological review of Ad8 in Southern Taiwan. Jpn J Ophthalmol 2001, 45:160-166.
32. Adhikary A.K., Numaga J., Kaburaki T., Kawashima H., Araie M., Ikeda Y., et al. Genetic characterization of adenovirus type 8 isolated in Hiroshima city over a 15 year period. J Clin Pathol 2003, 56:120-125.
33. Jin X.H., Aoki K., Kitaichi N., Ariga T., Ishida S., Ohno S. Genome variability of human adenovirus type 8 causing epidemic keratoconjunctivitis during 1986-2003 in Japan. Mol Vis 2001, 17:3121-3127.
34. Adrian T., Wolf U., Lauer H.J., Wigand R. Restriction site mapping of adenovirus type 8 genome types. Res Virol 1990, 141:611-624.
35. de Jong J.C., Demazure M., Legrand-Quillien M.C., Le Lay G., Colin J., Wermenbol A., et al. New developments in the molecular epidemiology of adenovirus 8 keratoconjunctivitis. J Med Virol 1992, 38:102-107.
36. Tanaka K., Itoh N., Saitoh-Inagawa W., Uchio E., Takeuchi S., Aoki K. Genetic characterization of adenovirus strains isolated from patients with acute conjunctivitis in the city of Sao Paulo, Brazil. J Med Virol 2000, 61:143-149.
37. Ishii K., Nakazono N., Fujinaga K., Fujii S., Kato M., Ohtsuka H., et al. Comparative studies on aetiology and epidemiology of viral conjunctivitis in three countries of East Asia-Japan, Taiwan and South Korea. Int J Epidemiol 1987, 16:98-103.
38. Fuchs E. Keratitis punctata superficialis. Wien Klin Wochenschr 1889, 2:837.
39. Wright R.E. Superficial punctate keratitis. Br J Ophthalmol 1930, 14:257.
40. Hogan M.J., Crawford J.W. Epidemic keratoconjunctivitis (superficial punctate keratitis, keratitis subepithelialis, keratitis maculosa, keratitis nummularis). With a review of the literature and a report of 125 cases. Am J Ophthalmol 1942, 25:1059-1078.
41. Jawetz E., Kimura S.J., Hanna L., Coleman V.R., Thygeson P., Nicholas A. Studies on the etiology of epidemic keratoconjunctivitis. Am J Ophthalmol 1955, 40:200-209.
42. Jawetz E., Thygeson P., Hanna L., Nicholas A., Kimura S.J. The etiology of epidemic keratoconjunctivitis. Am J Ophthalmol 1957, 43:79-83.
43. Jones B.R. The clinical features of viral keratitis and a concept of their pathogenesis. Proc R Soc Med 1958, 51:13-20.
44. Knappe S., Stave J., Guthoff R.F. Epidemic keratoconjunctivitis, in vivo images of corneal structures with the confocal Rostocker laser scanning microscope (RLSM). Ophthalmologe 2005, 102:798-801.
45. Tabbara K.F., Omar N., Hammouda E., Akanuma M., Ohguchi T., Ariga T., et al. Molecular epidemiology of adenoviral keratoconjunctivitis in Saudi Arabia. Mol Vis 2010, 16:2132-2136.
46. Hamada N., Gotoh K., Hara K., Iwahashi J., Imamura Y., Nakamura S., et al. Nosocomial outbreak of epidemic keratoconjunctivitis accompanying environmental contamination with adenoviruses. J Hosp Infect 2008, 68:262-268.
47. Gordon Y.J., Gordon R.Y., Romanowski E., Araullo-Cruz T.P. Prolonged recovery of desiccated adenoviral serotypes 5, 8, and 19 from plastic and metal surfaces in vitro. Ophthalmology 1993, 100:1835-1839.
48. Mema S.C., MacDonald J., Wyse J.P., Gonder T., Musto R., McIntyre L. Public health adds value to an investigation of epidemic keratoconjunctivitis. Can J Ophthalmol 2010, 45:538.
49. Kaneko H., Aoki K., Ohno S., Ishiko H., Fujimoto T., Kikuchi M., et al. Complete genome analysis of a novel intertypic recombinant human adenovirus causing epidemic keratoconjunctivitis in Japan. J Clin Microbiol 2011, 49:484-490.
50. Jin X.H., Ishiko H., Nguyen T.H., Ohguchi T., Akanuma M., Aoki K., et al. Molecular epidemiology of adenoviral conjunctivitis in Hanoi, Vietnam. Am J Ophthalmol 2006, 142:1064-1066.
51. Sendra-Gutiérrez J.M., Martín-Rios D., Casas I., Sáez P., Tovar A., Moreno C. An outbreak of adenovirus type 8 keratoconjunctivitis in a nursing home in Madrid. Euro Surveill 2004, 9:27-30.
52. Yağci R., Akçali A., Yağci S., Konno T., Ishiko H., Duman S., et al. Molecular identification of adenoviral conjunctivitis in Turkey. Eur J Ophthalmol 2010, 20:669-674.
53. Ersoy Y., Otlu B., Türkçüoğlu P., Yetkin F., Aker S., Kuzucu C. Outbreak of adenovirus serotype 8 conjunctivitis in preterm infants in a neonatal intensive care unit. J Hosp Infect 2012, 80:144-149.
54. Chaberny I.E., Schnitzler P., Geiss H.K., Wendt C. An outbreak of epidemic keratoconjunctivtis in a pediatric unit due to adenovirus type 8. Infect Control Hosp Epidemiol 2003, 24:514-519.
55. Hiroi S., Morikawa S., Takahashi K., Komano J., Kase T. Molecular epidemiology of human adenoviruses D associated with epidemic keratoconjunctivitis in Osaka, Japan, 2001-2010. Jpn J Infect Dis 2013, 66:436-438.
56. Janani M.K., Malathi J., Madhavan H.N. Isolation of a variant human adenovirus identified based on phylogenetic analysis during an outbreak of acute keratoconjunctivitis in Chennai. Indian J Med Res 2012, 136:260-264.
57. Tohma K., Bayasgalan N., Suzuki A., Darma B., Oshitani H., Nymadawa P. Detection and serotyping of human adenoviruses from patients with influenza-like illness in Mongolia. Jpn J Infect Dis 2012, 65:289-294.
58. Adenovirus-associated epidemic keratoconjunctivitis outbreaks-four states, 2008-2010. MMWR 2013, 62:637-641.
59. Meyer-Rüsenberg B., Loderstädt U., Richard G., Kaulfers P.M., Gesser C. Epidemic keratoconjunctivitis: the current situation and recommendations for prevention and treatment. Dtsch Arztebl Int 2011, 108:475-480.
60. Pihos A.M. Epidemic keratoconjunctivitis: a review of current concepts in management. J Optom 2013, 6:69-74.
61. Kaufman H.E. Adenovirus advances: new diagnostic and therapeutic options. Curr Opin Ophthalmol 2011, 22:290-293.
62. Morfin F., Dupuis-Girod S., Mundweiler S., Falcon D., Carrington D., Sedlacek P., et al. In vitro susceptibility of adenovirus to antiviral drugs is species-dependent. Antivir Ther 2005, 10:225-229.
63. Trinavarat A., Atchaneeyasakul L.O. Treatment of epidemic keratoconjunctivitis with 2% povidone-iodine: a pilot study. J Ocul Pharmacol Ther 2012, 28:53-58.
64. Laibson P.R. Ocular adenoviral infections. Ophthalmol Clin 1984, 24:49-64.
65. Freyler H., Sehorst W. The fate of corneal infiltrations in cases of epidemic keratoconjunctvitis. Wien Klin Wochenschr 1976, 28:341-343.
66. Aplander K., Marttila M., Manner S., Arnberg N., Sterner O., Ellervik U. Molecular wipes application to epidemic keratoconjuctivitis. J Med Chem 2011, 54:6670-6675.
67. Crawford-Miksza L.K., Nang R.N., Schnurr D.P. Strain variation in adenovirus serotypes 4 and 7a causing acute respiratory disease. J Clin Microbiol 1999, 37:1107-1112.
68. Hierholzer J.C., Stone Y.O., Broderson J.R. Antigenic relationships among the 47 human adenoviruses determined in reference horse antisera. Arch Virol 1991, 121:179-197.
69. Grayston J.T., Loosli C.G., Johnston P.B., Smith M.E., Woolridge R.L. Neutralizing and complement fixing antibody response to adenovirus infection. J Infect Dis 1956, 99:199.
70. Tai F.H., Grayston J.T. Adenovirus neutralizing antibodies in persons on Taiwan. Proc Soc Exp Biol Med 1962, 109:881.
71. Chapple P.J. A survey of antibodies to adenovirus 8 and coxsackievirus A21 in human sera. Bull World Health Organ 1966, 34:243-248.
72. Barnard D.L., Dean Hart J.C., Marmion V.J., Clarke S.K.R. Outbreak in Bristol of conjunctivitis caused by adenovirus type 8, and its epidemiology and control. Br Med J 1973, 2:165-169.
73. Misui Y., Hanna L., Minoda R., Ogata S., Kurihara H., Okamura R., et al. Experiments in human volunteers with adenovirus type 8. Br J Ophthalmol 1959, 43:540-547.
74. Gray G.C. Acute respiratory disease in the military. Fed Pract 1995, 12:27-33.
75. Gray G.C., Callahan J.D., Hawksworth A.W., Fisher C.A., Gaydos J.C. Respiratory diseases among U.S. military personnel: countering emerging threats. Emerg Infect Dis 1999, 5:379-385.
76. Yu P., Ma C., Nawaz M., Han L., Zhang J., Du Q., et al. Outbreak of acute respiratory disease caused by human adenovirus type 7 in a military training camp in Shaanxi, China. Microbiol Immunol 2013, 57:553-560.
77. Rubin B.A. Clinical picture and epidemiology of adenovirus infections. Acta Microbiol Hung 1993, 40:303-323.
78. Russell K.L., Hawksworth A.W., Ryan M.A., Strickler J., Irvine M., Hansen C.J., et al. Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004. Vaccine 2006, 24:2835-2842.
79. Wadell G. Molecular epidemiology of human adenoviruses. Curr Top Microbiol Immunol 1984, 110:191-220.
80. Wadell G., Hammarskjold M.L., Winberg G., Varsanyi T.M., Sundell G. Genetic variability of adenoviruses. Ann N Y Acad Sci 1980, 354:16-42.
81. Landry M.L., Lebeck M.G., Capuano A.W., McCarthy T., Gray G.C. Adenovirus type 3 outbreak in Connecticut associated with a novel variant. J Med Virol 2009, 81:1380-1384.
82. Arens M. Methods for subtyping and molecular comparison of human viral genomes. Clin Microbiol Rev 1999, 12:612-626.
83. Kajon A., Wadell G. Genome analysis of South American adenovirus strains of serotype 7 collected over a 7-year period. J Clin Microbiol 1994, 32:2321-2323.
84. Kajon A.E., Lu X., Erdman D.D., Louie J., Schnurr D., George K.S., et al. Molecular epidemiology and brief history of emerging adenovirus 14-associated respiratory disease in the United States. J Infect Dis 2010, 202:93-103.
85. Adhikary A.K., Hanaoka N., Fujimoto T. Simple and cost-effective restriction endonuclease analysis of human adenoviruses. Biomed Res Int 2014, 3.
86. Kaneko H., Suzutani T., Aoki K., Kitaichi N., Ishida S., Ishiko H., et al. Epidemiological and virological features of epidemic keratoconjunctivitis due to new human adenovirus type 54 in Japan. Br J Ophthalmol 2011, 95:32-36.
87. Walsh M.P., Chintakuntlawar A., Robinson C.M., Madisch I., Harrach B., Hudson N.R., et al. Evidence of molecular evolution driven by recombination events influencing tropism in a novel human adenovirus that causes epidemic keratoconjunctivitis. PLoS ONE 2009, 4:e5635.
88. Ishiko H., Aoki K. Spread of epidemic keratoconjunctivitis due to a novel serotype of human adenovirus in Japan. J Clin Microbiol 2009, 47:2678-2679.
89. Seto D., Jones M.S., Dyer D.W., Chodosh J. Characterizing, typing, and naming human adenovirus type 55 in the era of whole genome data. J Clin Virol 2013, 58:741-742.
90. Adhikary A.K., Ushijima H., Fujimoto T. Human adenovirus type 8 (HAdV-8) genome typing. J Med Microbiol 2012, 61:1491-1503.
91. Adrian T., Wadell G., Hierholzer J.C., Wigand R. DNA restriction analysis of adenovirus prototypes 1 to 41. Arch Virol 1986, 91:277-290.
92. Lole K.S., Bollinger R.C., Paranjape R.S., Gadkari D., Kulkarni S.S., Novak N.G., et al. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 1999, 73:152-160.
93. Ovcharenko I., Loots G.G., Hardison R.C., Miller W., Stubbs L. zPicture: dynamic alignment and visualization tool for analyzing conservation profiles. Genome Res 2004, 14:472-477.
94. Russell W.C. Adenoviruses: update on structure and function. J Gen Virol 2009, 9:1-20.
95. Adhikary A.K., Inada T., Banik U., Mukouyama A., Ikeda Y., Noda M., et al. Serological and genetic characterization of a unique strain of adenovirus involved in outbreak of epidemic keratoconjunctivitis (EKC). J Clin Pathol 2004, 57:411-416.
96. Schmitz H., Wigand R., Heinreich W. Worldwide epidemiology of adenovirus infections. Am J Epidemiol 1983, 117:455-466.
97. Yamadera S., Yamashita K., Akatsuka M., Kato N., Hashido M., Inouye S., et al. Adenovirus surveillance, 1982-1995, Japan. A report of the national epidemiological surveillance of infectious agents in Japan. Jpn J Med Sci Biol 1995, 48:199-210.
98. Crawford-Miksza L.K., Schnurr D.P. Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues. J Virol 1996, 70:1836-1844.
99. Pichla-Gollon S.L., Drinker M., Zhou X., Xue F., Rux J.J., Gao G.P., et al. Structure-based identification of a major neutralizing site in adenovirus hexon. J Virol 2006, 81:1680-1689.
100. Blasiole D.A., Metzgar D., Daum L.T., Ryan M.A.K., Wu J., Wills C., et al. Molecular analysis of adenovirus isolates from vaccinated and unvaccinated young adults. J Clin Microbiol 2004, 4:1686-1693.
101. Tian X., Su X., Xue C., Li X., Zhou Z., Zhou R. Antigenic variability among two subtypes of human adenovirus serotype 7. Virus Genes 2014, 49:22-29.
102. Mei Y.F., Wadell G. Epitopes and hemagglutination binding domain on subgenus B: 2 adenovirus fibers. J Virol 1996, 70:3688-3697.
103. Adhikary A.K., Inada T., Numaga J., Suzuki E., Ushijima H., Banik U., et al. Characterization of hexon and fiber genes of a novel strain of adenovirus involved in epidemic keratoconjunctivitis. J Clin Pathol 2004, 57:95-97.
104. Durand M.L., Weber D.J., Rutala W.A. Healthcare-associated eye infections. Hospital epidemiology and infection control 2012, 352-364. Lippincott Williams and Wilkins, Philadelphia. 4th ed. C.G. Mayhall (Ed.).
105. Jernigan J.A., Lowry B.S., Hayden F.G., Kyger S.A., Conway B.P., Gröschel D.H., et al. Adenovirus type 8 epidemic keratoconjunctivitis in an eye clinic: risk factors and control. J Infect Dis 1993, 167:1307-1313.
106. Koo D., Bouvier B., Wesley M., Courtright P., Reingold A. Epidemic keratoconjunctivitis in a university medical center ophthalmology clinic: need for re-evaluation of the design and disinfection of instruments. Infect Control Hosp Epidemiol 1989, 10:547-552.
107. Hara J., Okamoto S., Minekawa Y., Yamazaki K., Kase T. Survival and disinfection of adenovirus type 19 and enterovirus 70 in ophthalmic practice. Jpn J Ophthalmol 1990, 34:421-427.
108. Rutala W.A., Peacock J.E., Gergen M.F., Sobsey M.D., Weber D.J. Efficacy of hospital germicides against adenovirus 8, a common cause of epidemic keratoconjunctivitis in health care facilities. Antimicrob Agents Chemother 2006, 50:1419-1424.
109. Adhikary A.K., Numaga J., Kaburaki T., Kawashima H., Kato S., Araie M., et al. Rapid detection and typing of oculopathogenic strain of subgenus D adenoviruses by fiber-based PCR and restriction enzyme analysis. Invest Ophthalmol Vis Sci 2001, 42:2010-2015.